IOL Chemicals and Pharmaceuticals Limited Stock price

Equities

IOLCP

INE485C01011

Pharmaceuticals

Market Closed - Bombay S.E. 06:00:51 2024-03-28 am EDT 5-day change 1st Jan Change
361.5 INR +0.31% Intraday chart for IOL Chemicals and Pharmaceuticals Limited -6.03% -21.96%
Sales 2024 * 23.96B 288M Sales 2025 * 26.65B 320M Capitalization 21.22B 255M
Net income 2024 * 1.86B 22.29M Net income 2025 * 2.33B 27.98M EV / Sales 2024 * 0.89 x
Net cash position 2024 * - 0 Net cash position 2025 * - 0 EV / Sales 2025 * 0.8 x
P/E ratio 2024 *
11.4 x
P/E ratio 2025 *
8.48 x
Employees 2,569
Yield 2024 *
1.76%
Yield 2025 *
1.96%
Free-Float 37.75%
More Fundamentals * Assessed data
Dynamic Chart
IOL Chemicals Gets Zero Observations from Brazilian Health Regulatory Agency After Inspection of Units MT
IOL Chemicals Gets Nod to Export Diabetes Drug to China MT
IOL Chemicals and Pharmaceuticals Limited Announces CDE, China Approved Metformin Hydrochloride CI
Transcript : IOL Chemicals and Pharmaceuticals Limited, Q3 2024 Earnings Call, Feb 08, 2024
IOL Chemicals and Pharmaceuticals Limited Approves Closing of M/S Iol Global Limited, Uk, Wholly Owned Subsidiary of the Company CI
IOL Chemicals and Pharmaceuticals Limited Declares Interim Dividend for the Financial Year 2023-24 CI
IOL Chemicals and Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
Transcript : IOL Chemicals and Pharmaceuticals Limited, Q2 2024 Earnings Call, Nov 09, 2023
IOL Chemicals and Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
Transcript : IOL Chemicals and Pharmaceuticals Limited, Q1 2024 Earnings Call, Aug 16, 2023
CARE Keeps A+ Rating on IOL Chemicals' Long-term Bank Financing; Outlook Stable MT
IOL Chemicals Opens New Acetic Anhydride Facility MT
IOL Chemicals Granted New Patent in India MT
Transcript : IOL Chemicals and Pharmaceuticals Limited, Q4 2023 Earnings Call, May 09, 2023
IOL Chemicals Gets European Drug Regulator's Approval to Export Paracetamol MT
More news

Latest transcript on IOL Chemicals and Pharmaceuticals Limited

1 day+0.31%
1 week-6.03%
Current month-10.59%
1 month-9.26%
3 months-22.25%
6 months-22.45%
Current year-21.96%
More quotes
1 week
357.80
Extreme 357.8
388.10
1 month
350.30
Extreme 350.3
416.30
Current year
350.30
Extreme 350.3
497.60
1 year
281.55
Extreme 281.55
535.60
3 years
272.20
Extreme 272.2
725.00
5 years
147.35
Extreme 147.35
898.40
10 years
19.00
Extreme 19
898.40
More quotes
Managers TitleAgeSince
Chief Executive Officer - 23-04-02
Director of Finance/CFO - -
Compliance Officer - 19-11-13
Members of the board TitleAgeSince
Chairman 70 19-02-05
Director/Board Member 61 07-08-31
Director/Board Member - 14-08-21
More insiders
Date Price Change Volume
24-03-28 361.5 +0.31% 40,621
24-03-27 360.4 -4.59% 108,724
24-03-26 377.8 -2.31% 38,157
24-03-22 386.7 +0.52% 68,918
24-03-21 384.7 -1.85% 22,076

Delayed Quote Bombay S.E., March 28, 2024 at 06:00 am EDT

More quotes
IOL Chemicals and Pharmaceuticals Limited is engaged in manufacturing and selling of pharmaceutical and chemical products. The Company operates through two segments: Chemical, and Pharmaceutical. The Chemical segment produces and sells Ethyl Acetate, Iso Butyl Benzene, Acetyl Chloride, Mono Chloro Acetic Acid, Para Amino Phenol (PAP), and others. The Pharmaceutical segment produces and sells various active pharma ingredients (API) include Ibuprofen, Metformin, Fenofibrate, Lamotrigine, Clopidogrel Bisulphate, Pantoprazole, Gabapentin, Paracetamol, and others. Its API product portfolio includes Ibuprofen, Metformin HCL, Pantoprazole Sodium, Clopidogrel Bisulphate (Form II), Lamotrigine, Losartan Potassium, Levetiracetam, Paracetamol, Fenofibrate (Micronised), and Gabapentin. Its Specialty Chemical division includes Ethyl Acetate, and Acetic Anhydride. Its Ethyl Acetate is used in industries like flexible packaging, pharmaceuticals, ink, food processing, pesticides, and paint industry.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
361.5 INR
Average target price
517 INR
Spread / Average Target
+43.02%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock
  2. Equities
  3. Stock IOL Chemicals and Pharmaceuticals Limited - Bombay S.E.